IL4R and colorectal carcinoma: Recent advances have honed in on the physiological and biochemical pathways exploited by CRC to facilitate metastatic spread (2–5) and we have previously suggested that interleukin (IL)-4 receptor (IL4R) signaling is one such pathway (6–8).